KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Operating Margin (2016 - 2025)

Historic Operating Margin for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to 45.57%.

  • Eli Lilly's Operating Margin rose 75200.0% to 45.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 43.16%, marking a year-over-year increase of 92600.0%. This contributed to the annual value of 35.92% for FY2024, which is 58600.0% up from last year.
  • Latest data reveals that Eli Lilly reported Operating Margin of 45.57% as of Q3 2025, which was up 75200.0% from 45.13% recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Operating Margin ranged from a high of 45.57% in Q3 2025 and a low of 21.46% during Q2 2021
  • Its 5-year average for Operating Margin is 31.91%, with a median of 30.4% in 2021.
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -99300bps in 2023, then soared by 115000bps in 2025.
  • Quarter analysis of 5 years shows Eli Lilly's Operating Margin stood at 29.44% in 2021, then dropped by -3bps to 28.44% in 2022, then rose by 13bps to 32.19% in 2023, then rose by 23bps to 39.44% in 2024, then increased by 16bps to 45.57% in 2025.
  • Its last three reported values are 45.57% in Q3 2025, 45.13% for Q2 2025, and 41.38% during Q1 2025.